Gurugram Hospital has received a patent for an innovative brachytherapy device for advanced cervical cancer.

04 July 2024 22:27 IST

Gurugram (Haryana) [India], July 4 (ANI): A private hospital in Gurugram has received a patent for its innovative Medanta Anterior Oblique Lateral Oblique (MAOLO) template. This device can help treat tumors 100c and larger.
Dr. Naresh Trehan, Chairman and Managing Director, Medanta said, “At Medanta, our top priority is the well-being of our patients. The MAOLO template exemplifies our dedication to developing high-quality medical technologies that improve patient outcomes. This is not just a milestone for Medanta, but an important step forward for cervical cancer care in India and we will continue to provide solutions that meet the needs of our community. “
“It was conceptualized by Dr Suswan Banerjee, Associate Director, in collaboration with Dr Tejendra Kataria, Chairperson, Division of Radiation Oncology, Cancer Institute, and the Medanta Medical Physics team. MAOLO 100cc ( (cubic centimeters) and more, while commercially available intracautery applicators appear to be effective against tumors of 36cc or less,” released by the hospital. said in a statement.

According to a statement released by Medanta, this innovation marks a significant improvement in the treatment of cervical cancer, the second most common cancer among women in India. Cervical cancer in India claims 2/3 of all cases, despite being 98% curable with the vaccine and the PAP smear test in the early stages of the disease, and 95% curable in the early stages of the disease. does because of late presentation when large and bulky tumors have spread to the posterior pelvic wall.
Brachytherapy, also called plesiotherapy, places the radiation source close to the tumor – on the surface of the skin, mucosa, inside tissue or in cavities. It uses a higher total dose of radiation to treat a smaller area than external beam radiation therapy, which directs high-energy X-rays (radiation) at the tumor from outside the body. Since the 1930s, brachytherapy has been used to treat oral or tongue cancer, soft tissue sarcoma (for organ preservation) and cervical cancer with excellent results.
Dr. Tejendra Kataria, Chairperson, Radiation Oncology, Cancer Institute, Medanta, said, “In India, commercially available interstitial and intracavitary combo applicators are numerous, and access is limited. Time, training and skill are required, as they come in multiple components and can be applied only by suturing the patient's skin, making them uncomfortable, the duration of general and spinal anesthesia. , the need for pain medication, and may also increase the length of admission.”
Dr Suswan Banerjee, Associate Director, Radiation Oncology, Medanta, explains the impetus for the device. “Available applicators, in addition to being bulky and cumbersome, have insufficient geometrical coverage for large disease volumes, leading to recurrences. Therefore, we saw the need to design a new device that would address our clinical issues. can provide a local solution.”
“MAOLO is a disc-shaped device that allows placement of a large number of catheters in three directions. This design makes it useful in addressing some of the larger tumors presented clinically. This single-piece template The improved technology eliminates the need for assembly, makes it easier to use by technical staff and reduces the margin of error. Being cylindrical, MAOLO can be safely placed in the vagina and It's more comfortable and eliminates bleeding, pain, discomfort, or geometric asymmetry (geographic miss), problems that can lead to procedure abandonment,” Dr. Banerjee explained. (ANI)

Leave a Comment

“The Untold Story: Yung Miami’s Response to Jimmy Butler’s Advances During an NBA Playoff Game” “Unveiling the Secrets: 15 Astonishing Facts About the PGA Championship”